Jana Kyrova1, Lenka Kopeckova2, Hana Buckova1, Lenka Mrazova3, Karel Vesely4, Marketa Hermanova4, Hana Oslejskova3, Lenka Fajkusova2. 1. Department of Pediatric Dermatology, Pediatric Clinic, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic; ; EB Centre Czech Republic, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic. 2. Centre of Molecular Biology and Gene Therapy, University Hospital Brno and Masaryk University Brno, Brno, Czech Republic. 3. Clinic of Pediatric Neurology, University Hospital and Masaryk University Brno, Brno, Czech Republic. 4. 1st Department of Pathological Anatomy, St. Anne´s University Hospital Brno and Masaryk University Brno, Brno, Czech Republic.
Abstract
BACKGROUND: Epidermolysis bullosa simplex associated with muscular dystrophy is a genetic skin disease caused by plectin deficiency. A case of a 19-year-old Czech patient affected with this disease and a review all previously published clinical cases are presented. MAIN OBSERVATIONS: In our patient, skin signs of the disease developed after birth. Bilateral ptosis at the age of 8 years was considered as the first specific symptom of muscular dystrophy. Since then, severe scoliosis, urological and psychiatric complication have quickly developed. The signs of plectin deficiency were found by histopathological studies, electron microscopy and antigen mapping of the skin and muscular samples. Two autosomal recessive mutations in the plectin gene leading to premature termination codon were disclosed by mutation analysis. By review of all published clinical cases, 49 patients with this disease were found. 54 different mutations in the plectin gene were published, p.(Arg2319*) in exon 31 being the most frequently found. Median age of muscular dystrophy development was 9.5 years. Hoarseness and respiratory complications were the most often complications beside skin involvement. CONCLUSION: Epidermolysis bullosa simplex with muscular dystrophy was diagnosed based on clinical, histopathological (skin and muscle biopsy) and mutation analysis of the plectin gene. Overview of the genetic and clinical characteristic of this disease could be presented by review of all previously published clinical cases.
BACKGROUND:Epidermolysis bullosa simplex associated with muscular dystrophy is a genetic skin disease caused by plectin deficiency. A case of a 19-year-old Czech patient affected with this disease and a review all previously published clinical cases are presented. MAIN OBSERVATIONS: In our patient, skin signs of the disease developed after birth. Bilateral ptosis at the age of 8 years was considered as the first specific symptom of muscular dystrophy. Since then, severe scoliosis, urological and psychiatric complication have quickly developed. The signs of plectin deficiency were found by histopathological studies, electron microscopy and antigen mapping of the skin and muscular samples. Two autosomal recessive mutations in the plectin gene leading to premature termination codon were disclosed by mutation analysis. By review of all published clinical cases, 49 patients with this disease were found. 54 different mutations in the plectin gene were published, p.(Arg2319*) in exon 31 being the most frequently found. Median age of muscular dystrophy development was 9.5 years. Hoarseness and respiratory complications were the most often complications beside skin involvement. CONCLUSION:Epidermolysis bullosa simplex with muscular dystrophy was diagnosed based on clinical, histopathological (skin and muscle biopsy) and mutation analysis of the plectin gene. Overview of the genetic and clinical characteristic of this disease could be presented by review of all previously published clinical cases.
Authors: Maria C Bolling; Hendri H Pas; Marianne de Visser; Eleonora Aronica; Ellen G Pfendner; Maarten P van den Berg; Gilles F H Diercks; Albert J H Suurmeijer; Marcel F Jonkman Journal: J Invest Dermatol Date: 2009-12-17 Impact factor: 8.551
Authors: J W Bauer; F Rouan; B Kofler; G A Rezniczek; I Kornacker; W Muss; R Hametner; A Klausegger; A Huber; G Pohla-Gubo; G Wiche; J Uitto; H Hintner Journal: Am J Pathol Date: 2001-02 Impact factor: 4.307
Authors: Katarzyna B Gostyńska; Miranda Nijenhuis; Henny Lemmink; Hendri H Pas; Anna M G Pasmooij; Kristin Kernland Lang; Maria J Castañón; Gerhard Wiche; Marcel F Jonkman Journal: Hum Mol Genet Date: 2015-02-24 Impact factor: 6.150
Authors: S Chavanas; L Pulkkinen; Y Gache; F J Smith; W H McLean; J Uitto; J P Ortonne; G Meneguzzi Journal: J Clin Invest Date: 1996-11-15 Impact factor: 14.808
Authors: D Koss-Harnes; B Høyheim; M F Jonkman; W P de Groot; C J de Weerdt; B Nikolic; G Wiche; T Gedde-Dahl Journal: Acta Derm Venereol Date: 2004 Impact factor: 4.437
Authors: C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno Journal: Br J Dermatol Date: 2019-08-09 Impact factor: 9.302
Authors: Joana G P Jacinto; Irene M Häfliger; Inês M B Veiga; Cord Drögemüller; Jørgen S Agerholm Journal: J Vet Intern Med Date: 2020-11-02 Impact factor: 3.333